CSPC Pharmaceutical Group Limited

OTCPK:CHJT.F Stock Report

Market Cap: US$11.8b

CSPC Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CHJT.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Apr 25BuyUS$3,523,905Dongchen CaiIndividual4,500,000US$0.78
24 Apr 25BuyUS$4,525,122Dongchen CaiIndividual5,780,000US$0.78
09 Apr 25BuyUS$604,814Dongchen CaiIndividual1,000,000US$0.60
08 Apr 25BuyUS$1,448,220Dongchen CaiIndividual2,350,000US$0.62
07 Apr 25BuyUS$4,124,815Dongchen CaiIndividual6,700,000US$0.62
06 Jan 25SellUS$5,288,038UBS Asset Management AGCompany9,008,000US$0.59
13 Dec 24BuyUS$617,035Dongchen CaiIndividual1,000,000US$0.62
27 Nov 24BuyUS$314,989Dongchen CaiIndividual484,000US$0.65
26 Nov 24BuyUS$261,072Dongchen CaiIndividual400,000US$0.65
25 Nov 24BuyUS$653,064Dongchen CaiIndividual1,000,000US$0.65
22 Nov 24BuyUS$661,533Dongchen CaiIndividual1,000,000US$0.66
21 Nov 24BuyUS$133,875Dongchen CaiIndividual200,000US$0.67
19 Nov 24BuyUS$263,384Dongchen CaiIndividual400,000US$0.66
09 Sep 24BuyUS$591,519Dongchen CaiIndividual1,000,000US$0.59
29 Aug 24BuyUS$616,678Dongchen CaiIndividual1,000,000US$0.62
29 Aug 24BuyUS$121,822Hao JiangIndividual200,000US$0.61
28 Aug 24BuyUS$1,032,045Dongchen CaiIndividual1,700,000US$0.61
28 Aug 24SellUS$6,117,032BlackRock, Inc.Company10,016,000US$0.61
26 Aug 24BuyUS$490,850Dongchen CaiIndividual800,000US$0.61
23 Aug 24BuyUS$730,168Dongchen CaiIndividual1,200,000US$0.61
22 Aug 24BuyUS$862,143Dongchen CaiIndividual1,378,000US$0.63
22 Aug 24BuyUS$627,507Cuilong ZhangIndividual1,000,000US$0.63

Insider Trading Volume

Insider Buying: CHJT.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CHJT.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies755,785,3136.61%
Individual Insiders2,854,287,67025%
Institutions3,472,599,00930.4%
General Public4,346,152,94038%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 56.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.9%
Dongchen Cai
2,840,267,670US$2.9b0.72%no data
6.38%
Common Success International Limited
728,796,313US$752.9m0%no data
4.64%
BlackRock, Inc.
530,338,510US$547.9m0.13%0.01%
3.51%
UBS Asset Management AG
401,251,382US$414.5m-0.86%0.03%
3.15%
The Vanguard Group, Inc.
360,422,338US$372.3m-1.37%no data
2.04%
Norges Bank Investment Management
232,933,324US$240.6m0%0.02%
1.93%
First Sentier Investors (Australia) IM Ltd
220,436,494US$227.7m0%0.58%
1.26%
Bosera Asset Management Co., Ltd.
143,912,000US$148.7m0%0.58%
1.12%
State Street Global Advisors, Inc.
128,177,120US$132.4m0.62%no data
1.11%
Dimensional Fund Advisors LP
126,735,873US$130.9m-1.14%0.02%
0.88%
Aberdeen Group Plc
100,513,537US$103.8m0%0.06%
0.72%
GF Fund Management Co., Ltd.
81,780,000US$84.5m0%0.16%
0.64%
China Asset Management Co. Ltd.
73,414,129US$75.8m-6.65%0.07%
0.64%
Geode Capital Management, LLC
73,368,042US$75.8m2.72%no data
0.63%
Harvest Fund Management Co. Ltd.
71,474,040US$73.8m0%0.13%
0.51%
Caisse de dépôt et placement du Québec
58,092,837US$60.0m0%0.05%
0.48%
Hang Seng Investment Management Limited
54,340,284US$56.1m4.39%0.44%
0.34%
Zhong Ou Fund Management Co., Ltd
39,100,000US$40.4m0%0.15%
0.33%
Schroder Investment Management (Hong Kong) Ltd.
37,590,000US$38.8m0%0.2%
0.31%
UBS SDIC Fund Management Co., Ltd.
35,566,640US$36.7m0%0.8%
0.31%
Eastspring Investments (Singapore) Limited
35,410,800US$36.6m0%0.1%
0.31%
American Century Investment Management Inc
35,206,932US$36.4m3.41%0.02%
0.29%
E Fund Management Co., Ltd.
32,668,295US$33.7m0%0.03%
0.25%
Amundi Asset Management SAS
28,391,599US$29.3m0%0.01%
0.24%
Massive Top Limited
26,880,000US$27.8m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/31 02:00
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 54 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sharon ShiBOCI Research Ltd.
Wai Chak YuenBOCI Research Ltd.
Ethan CuiBofA Global Research